Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant infusional 5-fluorouracil + irinotecan versus observation in resected stage II colon cancer
2004-001858-90Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Nov 2004
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of irinotecan, fluorouracil and folinic acid in colon cancer (2 arms), sponsored by European Organisation for Research and Treatment of Cancer. Primary endpoint: 5-year disease-free survival. Started Nov 2004; status: completed.
02
Drugs
irinotecanfluorouracilfolinic acid
03
Conditions
colon cancer
Beyond the preview
Go deeper on 2004-001858-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001858-90.